Physician profile

Randall E Herrin

Emergency Medicine · Tulsa, OK

NPI 1942231261

$360.94

in general payments reported to CMS, 2019-2025

7 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$42.81

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Portola Pharmaceuticals, LLC $150.31 2019
Stryker Corporation $55.18 2021
Henry Schein, INC. $48.18 2019
Pfizer INC. $32.95 2020-2024
Global Blood Therapeutics, INC. $29.38 2020-2021
Inari Medical, INC. $22.72 2024 Flowtriever Catheter, S, Ct Thrombectomy System Kit
Janssen Pharmaceuticals, INC $22.22 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Randall E Herrin

$360.94

in general payments reported 2019-2025

Years
2019-2024
Top company
Portola Pharmaceuticals, LLC

https://glasscript.com/doctor/646361/randall-e-herrin

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.